Effect of IATP on Cognitive Functioning in Anxious Older Adults.
A Pilot Study on Randomized Control Trial Comparing Integrated Attention Training Program (IATP) and Health Education on Preservation of Cognitive Functioning in Chinese Older Adults With Anxiety Symptoms.
1 other identifier
interventional
48
1 country
1
Brief Summary
Older adults with anxiety symptoms was found to be associated with greater risk of dementia. Interventions targeting signs as early as in the pre-symptomatic phase could be most effective in early prevention of dementia. On reviewing the identified non-pharmacological interventions, integrated attention training program (IATP) is proposed to target older adults with anxiety symptoms in Hong Kong.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 13, 2018
CompletedStudy Start
First participant enrolled
August 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 7, 2019
CompletedFirst Posted
Study publicly available on registry
June 4, 2020
CompletedJune 4, 2020
May 1, 2020
5 months
August 13, 2018
May 28, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Attention network test (ANT)
ANT will measure the changes in attention from baseline to endpoint between the intervention and control groups. Performance was based on (i) accuracy refers to the degree of correctness and also to quality control, which means that if the participant's accuracy fell below 70%, the case would be considered unqualified. (2) reaction time refers to the processing speed. Median values of RT will be used as raw scores to avoid the influence of outliers. The indices will be served to compare the effect of IATP and health education.
T1: baseline, T2: 4th week, T3:12th week
Secondary Outcomes (12)
Subjective memory complaints (SMC)
T1: baseline, T2: 4th week, T3:12th week
Clinical Dementia Rating (CDR)
T1: baseline, T2: 4th week, T3:12th week
Digit and visual spans
T1: baseline, T2: 4th week, T3:12th week
Delayed recall
T1: baseline, T2: 4th week, T3:12th week
Category verbal fluency tests
T1: baseline, T2: 4th week, T3:12th week
- +7 more secondary outcomes
Study Arms (2)
Integrated Attention Training Program
EXPERIMENTALThe intervention group (I) will receive "integrated attention training program (IATP)" on a variety of structured attention tasks by an intervention instructor. It is considered to be simple and safe but effective enough for cognitive health promotion.
Health Education
PLACEBO COMPARATORThe control group (C) will receive health educational sessions on health concerns and physical diseases commonly found in old age during the invention period.
Interventions
Integrated attention training program (IATP) is a newly developed cognitive training programs that combined relaxation technique with integrated attentional training into daily life activity.
Health educational sessions on health concerns and physical diseases commonly found in old age
Eligibility Criteria
You may qualify if:
- Older adults aged 60 - 90 years; and
- Presence of subjective memory complaints as measured by memory inventory for the Chinese; and
- Anxiety symptoms as measured by Hamilton Anxiety Scale (HAM-A) with a score of 18 or above (indicated as mild anxiety symptoms).
You may not qualify if:
- DSM-5 diagnosis of either Major Neurocognitive Disorder due to AD, or Major Vascular Neurocognitive Disorder with small vessel disease. This would include satisfying criteria for significant cognitive decline in at least one of six areas of cognition (memory, perceptual-motor, complex attention, language, executive function and social cognition), and with clinical or neuroimaging features indicative of either AD or small vessel disease; or;
- Clinical dementia rating larger than or equal to 0.5; or
- Clinically depressed as assessed by Hamilton Depression Rating Scale with a score of 20 or higher; or
- Past history of major depressive episode, bipolar affective disorders or psychosis; or
- Physical frailty that may affect attendance to training sessions; or
- Currently on psychotropic or other medications know to affect cognition (e.g., benzodiazepines, anti-dementia medication, etc.); or
- Participants in other cognitive training or intervention for brain health during the study period; or
- Presence of major neurological deficit including history of stroke, transient ischemic attack or traumatic brain injury; or
- Significant communicative impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hong Kong Polytechnic University
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wai Tung Fung, PhD
The Hong Kong Polytechnic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 13, 2018
First Posted
June 4, 2020
Study Start
August 13, 2018
Primary Completion
December 31, 2018
Study Completion
January 7, 2019
Last Updated
June 4, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share